[1]李佳琳,冯晓娜,宋继荣,等.子宫内膜癌免疫微环境的研究进展[J].中国老年学杂志,2023,43(18):4604-4607.
LI JL,FENG XN,SONG JR,et al.Progress in the immune microenvironment of endometrial carcinoma [J].Chinese Journal of Gerontology,2023,43(18):4604-4607.
[2]陈姝宁,孔为民.子宫内膜癌规范化治疗与新进展[J].中国临床医生杂志,2023,51(3):263-267.
CHEN SN,KONG Weimin.Normalized treatment of endometrial cancer [J].Chinese Journal of Clinicians,2023,51(3):263-267.
[3]栗三东,钱文平,王金桃,等.一种简便实用的子宫内膜癌分子分型方法应用分析[J].现代肿瘤医学,2024,32(21):4115-4120.
LI SD,QIAN WP,WANG JT,et al.A simple and practical molecular typing method for endometrial cancer analysis[J].Modern Oncology,2024,32(21):4115-4120.
[4]张育军,魏丽惠,孙铁铮.子宫内膜癌组织中抑癌基因PTEN突变和表达的探讨[J].中国肿瘤临床,2023,30(2):104-108.
ZHANG YJ,WEI LH,SUN TZ.Exploring the PTEN mutation and expression of the tumor suppressor gene in endometrial cancer tissue [J].Oncology Clinical China,2023,30(2):104-108.
[5]胡帅,武霞,晋雨楠,等.SPP1和PD-L1在子宫内膜癌组织中的表达及其预后价值[J].现代肿瘤医学,2024,32(21):4121-4126.
HU S,WU X,JIN YN,et al.Expression of SPP 1 and PD-L1 in endometrial cancer tissues and their prognostic value[J].Modern Oncology,2024,32(21):4121-4126.
[6]唐峰,刘涛,廖义翔,等.细胞分裂周期相关蛋白2在恶性肿瘤中的研究进展[J].中华实验外科杂志,2022,39(12):2488-2490.
TANG F,LIU T,LIAO YX,et al.Progress in cell division cycle-related protein 2 in malignant tumors [J].Chinese Journal of Experimental Surgery,2022,39(12):2488-2490.
[7]XIANG N,CHEN T,ZHAO X,et al.In vitro assessment of roles of PPP1R14B in cervical and endometrial cancer[J].Tissue and Cell,2022,77(8):101845.
[8]HE K,WANG T,HUANG X,et al.PPP1R14B is a diagnostic prognostic marker in patients with uterine corpus endometrial carcinoma[J].J Cell Mol Med,2023,27(6):846-863.
[9]张萌,张珊,王芸芸,等.子宫内膜癌患者术后复发的列线图预测模型建立及其临床应用价值[J].现代妇产科进展,2023,32(5):349-354.
ZHANG M,ZHANG S,WANG YY,et al.Establishment of a nomogram prediction model of postoperative recurrence in endometrial cancer patients and its clinical application value [J].Progress in Modern Obstetrics and Gynecology,2023,32(5):349-354.
[10]刘叶,刘小云,颜淑梅,等.二代测序在子宫内膜癌分子分型的临床应用[J].中山大学学报(医学科学版),2023,44(2):217-223.
LIU Y,LIU XY,YAN SM,et al.Clinical application of second-generation sequencing in molecular typing of endometrial cancer [J].Journal of Sun Yat-sen University (Medical Science Edition),2023,44(2):217-223.
[11]任润玲,闫志风,李明霞,等.特殊病理类型子宫内膜癌分子分型特征及其临床应用的研究进展[J].解放军医学院学报,2023,44(3):287-292.
REN RL,YAN ZF,LI MX,et al.Progress in molecular classification of endometrial cancer and its clinical application [J].Journal of PLA Medical College,2023,44 (3):287-292.
[12]田书凝,张雯晴,张慧林.子宫内膜癌分子分型及临床应用的研究进展[J].临床肿瘤学杂志,2023,28(4):371-376.
TIAN SN,ZHANG WQ,ZHANG HL.Progress in the molecular classification and clinical application of endometrial cancer [J].Journal of Clinical Oncology,2023,28 (4):371-376.
[13]LI Z,YU L,ZHANG Y,et al.Identification of human,mouse and rat PPP1R14A,protein phosphatase-1 inhibitor subunit 14A,& mapping human PPP1R14A to chromosome 19q13.13-q13.2[J].Molecular Biology Reports,2021,28(2):91-101.
[14]何康.自由滚轮运动下调PPP1R14B抑制宫颈癌的作用及机制研究[D].长春:吉林大学,2024.
HE K.Effect and mechanism of PPP1R14B inhibition of cervical cancer[D].Changchun:Jilin University,2024.
[15]JOHNSON H,NARAYAN S,SHARMA AK.Altering phosphorylation in cancer through PP2A modifiers[J].Cancer Cell Int,2024,24(1):11.
[16]CHENG L,MI J,ZHANG J,et al.Upregulated PPP1R14B is connected to cancer progression and immune infiltration in kidney renal clear cell carcinoma[J].Clin Transl Oncol,2024,26(1):119-135.
[17]马俊杰,张磊,陆进,等.PPP1R14A基因与头颈鳞状细胞癌免疫治疗耐药相关:综合分析单细胞和批量测序结果(英文)[J].Chinese Medical Sciences Journal,2024,39(02):111-121.
MA JJ,ZHANG L,LU J,et al.PPP1R14A gene associated with immunotherapy resistance to head and neck squamous cell carcinoma:comprehensive analysis of single cell and bulk sequencing results (English) [J].Chinese Medical Sciences Journal,2024,39(02):111-121.
[18]DENG M,PENG L,LI J,et al.PPP1R14B is a prognostic and immunological biomarker in pan-cancer [J/OL].Front Genet,2021,12:763561.
[19]简肖肖,张万鹏,常艳,等.蛋白磷酸酶1调节亚基14B对神经母细胞瘤细胞有丝分裂进程的调控作用[J].中国药理学与毒理学杂志,2023,37(9):688-694.
JIAN XX,ZHANG WP,CHANG Y,et al.Regulation of protein phosphatase 1 regulatory subunit 14B on mitotic progression in neuroblastoma cells [J].Chinese Journal of Pharmacology and Toxicology,2023,37(9):688-694.
[20]MOSQUERA ORGUEIRA A,ANTELO RODRIGUEZ B,DIAZ ARIAS JA,et al.A three-gene expression signature identiffes a cluster of patients with short survival in chronic lymphocytic leukemia[J].J Oncol,2019,94(53):539-546.